首页> 外国专利> --- Succinate-poly-caprolactone-succinate Polymers Self-assembled Drug Delivery Nanoparticles Made thereby and Composition Comprising the Same

--- Succinate-poly-caprolactone-succinate Polymers Self-assembled Drug Delivery Nanoparticles Made thereby and Composition Comprising the Same

机译:---琥珀酸酯-聚己内酯-琥珀酸酯聚合物自组装的药物递送纳米颗粒及其组成

摘要

The present invention relates to succinate-PCL-succinate (snPCL) represented by the following formula (1) wherein succinate is covalently bonded to both ends of poly (ε-caprolactone; Polymer, snPCL nanoparticles prepared therefrom, and anticancer or nano drug delivery compositions comprising the snPCL nanoparticles, wherein the snPCL polymer synthesized in the dumbbell shape forms nanoparticles through self-assembly in an aqueous phase, and the thus formed snPCL nanoparticles Can act as a nano-anti-cancer drug that can selectively kill cancer cells, and can also deliver drugs into cells by encapsulating various drugs, thereby enhancing normal cell function or inducing the death of cancer cells; [Chemical Formula 1] In Formula 1, n is 3 to 30.
机译:本发明涉及由下式(1)表示的琥珀酸酯-PCL-琥珀酸酯(snPCL),其中琥珀酸酯共价键合于聚(ε-己内酯;聚合物;由其制备的snPCL纳米颗粒;和抗癌或纳米药物递送组合物包含snPCL纳米颗粒,其中以哑铃形状合成的snPCL聚合物通过在水相中自组装形成纳米颗粒,并且由此形成的snPCL纳米颗粒可以充当可以选择性杀死癌细胞的纳米抗癌药物,并且可以通过包封各种药物也可以将药物递送到细胞中,从而增强细胞的正常功能或诱导癌细胞的死亡; [化学式1]在式1中,n为3至30。

著录项

  • 公开/公告号KR101982671B1

    专利类型

  • 公开/公告日2019-05-27

    原文格式PDF

  • 申请/专利权人 가톨릭대학교 산학협력단;

    申请/专利号KR20170120398

  • 发明设计人 강한창;권기윤;

    申请日2017-09-19

  • 分类号C08G63/08;A61K31/704;A61K9/51;

  • 国家 KR

  • 入库时间 2022-08-21 11:48:29

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号